Frontiers in Digital Health (Oct 2021)

DCTclock: Clinically-Interpretable and Automated Artificial Intelligence Analysis of Drawing Behavior for Capturing Cognition

  • William Souillard-Mandar,
  • William Souillard-Mandar,
  • William Souillard-Mandar,
  • Dana Penney,
  • Dana Penney,
  • Braydon Schaible,
  • Alvaro Pascual-Leone,
  • Alvaro Pascual-Leone,
  • Alvaro Pascual-Leone,
  • Alvaro Pascual-Leone,
  • Rhoda Au,
  • Randall Davis,
  • Randall Davis

DOI
https://doi.org/10.3389/fdgth.2021.750661
Journal volume & issue
Vol. 3

Abstract

Read online

Developing tools for efficiently measuring cognitive change specifically and brain health generally—whether for clinical use or as endpoints in clinical trials—is a major challenge, particularly for conditions such as Alzheimer's disease. Technology such as connected devices and advances in artificial intelligence offer the possibility of creating and deploying clinical-grade tools with high sensitivity, rapidly, cheaply, and non-intrusively. Starting from a widely-used paper and pencil cognitive status test—The Clock Drawing Test—we combined a digital input device to capture time-stamped drawing coordinates with a machine learning analysis of drawing behavior to create DCTclock™, an automated analysis of nuances in cognitive performance beyond successful task completion. Development and validation was conducted on a dataset of 1,833 presumed cognitively unimpaired and clinically diagnosed cognitively impaired individuals with varied neurological conditions. We benchmarked DCTclock against existing clock scoring systems and the Mini-Mental Status Examination, a widely-used but lengthier cognitive test, and showed that DCTclock offered a significant improvement in the detection of early cognitive impairment and the ability to characterize individuals along the Alzheimer's disease trajectory. This offers an example of a robust framework for creating digital biomarkers that can be used clinically and in research for assessing neurological function.

Keywords